Lupin Gets U.S. FDA Approval for Ranluspec™ to Treat Retinal Disorders
Lupin Limited has secured U.S. FDA approval for Ranluspec™ (ranibizumab-hkdz), an interchangeable biosimilar to Genentech’s Lucentis® — a milestone that reshapes patient access to sight-saving biologics across...
Glenmark Launches Generic Vimpat®️ Injection in the US to Expand Injectable Portfolio
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the official launch of its Lacosamide Injection USP, 200mg/mL,20mg/mL, 10mg/mL available in Single-Dose Vials, as detailed in the official...
Telangana & South Africa Forge Strategic Alliance in Pharma, Medical Tourism, and ‘Bharat Future City
Telangana Chief Minister A Revanth Reddy hosted a high-level bilateral meeting with a South African delegation led by Deputy President Paul Mashatile to expand...
24 Nations, One Standard — India’s Pharmacopoeia Goes Global
The Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding with Lao PDR's Food and Drug Department and Ministry of Health, marking a...
CDSCO Advises Pharma Companies to Track and Report Drug Side Effects
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has issued a firm directive to all medicine manufacturers to build and maintain proper...
Emcure and Roche Collaborate to Improve Access to Advanced Nephrology Care
Emcure Pharmaceuticals has entered into a distribution agreement with Roche India for select products in nephrology and transplantation, marking a strategic step in expanding...
